Volume 28, Issue 2 pp. 729-731
Case Study

Episodic hyperCKaemia may be a feature of α-methylacyl-coenzyme A racemase deficiency

B. Krett

Corresponding Author

B. Krett

Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Correspondence: B. Krett, Copenhagen Neuromuscular Center, section 8077, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark (tel.: +45 3545 6135; fax: +4535456138; e-mail: [email protected]).

Contribution: ​Investigation (equal), Writing - original draft (lead), Writing - review & editing (equal)

Search for more papers by this author
V. Straub

V. Straub

John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

Search for more papers by this author
J. Vissing

J. Vissing

Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for more papers by this author
First published: 12 October 2020
Citations: 9

Abstract

α-methylacyl-CoA racemase (AMACR) deficiency is a rare disorder, affecting peroxisomal metabolism of pristanic acid, with ten published adult cases. We describe an AMACR deficiency case with a clinical presentation dominated by episodic hyperCKaemia, suggesting that myopathic features of AMACR should be considered.

Disclosure of conflicts of interest

The authors declare that they have no conflicts of interest.

Data availability statement

The data concerning the published patient are available upon request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.